Published
This week in oncology: TuHURA launches a Phase 3 trial of IFx-2.0 with Keytruda in Merkel Cell Carcinoma, while the FDA approves Datroway for EGFR-mutant lung cancer. The UK greenlights Hetronifly for small cell lung cancer, and China accepts CARsgen’s satri-cel NDA—the first CAR-T for solid tumors. Revolution Medicines secures Breakthrough status for daraxonrasib in pancreatic cancer. Additional highlights include approvals in liver cancer, trial launches in ovarian cancer, and a $750M CDK2 degrader deal between Gilead and Kymera. Stay tuned for more oncology breakthroughs.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
06:46
Transformative Advances in Precision Oncology and ADCs
-
04:12
Recent advances in precision oncology and future implications
-
04:44
Clinical Trials in Oncology: Episode 3
-
05:52
Latest Oncology Advances: Key Approvals and Late-Stage Trial Wins
-
04:29
Oncology Update: Keytruda Trials, CAR-T Advances & More
-
05:30
Class-59: Understanding OR, HR, CI & p-Values in Oncology Clinical Trials
-
05:24
Clinical Trials in Oncology: Episode 2
-
15:58
Basics of Oncology & Cancer Clinical Trials | Online Certification #oncology #cancer #education
-
04:31
Clinical Trials in Oncology: Episode 1
-
04:42
Clinical Trials with MN Oncology
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
